Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1991 Mar;84(3):159–162. doi: 10.1177/014107689108400315

Modern treatment strategies for patients with epilepsy: a review.

J S Duncan 1
PMCID: PMC1293137  PMID: 2013897

Abstract

Of patients who develop epilepsy 70-80% will become seizure free, the remaining 20% are the most difficult to treat satisfactorily. Eighty per cent of patients are best treated with a single drug. Stepwise treatment plans for the treatment of newly diagnosed patients and for the evaluation of patients with chronic epilepsy are suggested. There is a lack of consensus regarding the rate at which to taper antiepileptic drugs being discontinued in patients with active epilepsy. There are arguments for making drug changes rapidly; these arguments and strategies for managing the withdrawal of individual drugs are presented.

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albright P., Bruni J. Reduction of polypharmacy in epileptic patients. Arch Neurol. 1985 Aug;42(8):797–799. doi: 10.1001/archneur.1985.04210090065017. [DOI] [PubMed] [Google Scholar]
  2. Alvarez N., Hazlett J. Seizure management with minimal medications in institutionalized mentally retarded epileptics. A prospective study. First report after 4 1/2 years of follow up. Clin Electroencephalogr. 1983 Jul;14(3):164–172. doi: 10.1177/155005948301400312. [DOI] [PubMed] [Google Scholar]
  3. Bennett H. S., Dunlop T., Ziring P. Reduction of polypharmacy for epilepsy in an institution for the retarded. Dev Med Child Neurol. 1983 Dec;25(6):735–737. doi: 10.1111/j.1469-8749.1983.tb13841.x. [DOI] [PubMed] [Google Scholar]
  4. Callaghan N., O'Callaghan M., Duggan B., Feely M. Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. J Neurol Neurosurg Psychiatry. 1978 Oct;41(10):907–912. doi: 10.1136/jnnp.41.10.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Callaghan N., O'Dwyer R., Keating J. Unnecessary polypharmacy in patients with frequent seizures. Acta Neurol Scand. 1984 Jan;69(1):15–19. doi: 10.1111/j.1600-0404.1984.tb07774.x. [DOI] [PubMed] [Google Scholar]
  6. Chadwick D., Reynolds E. H. When do epileptic patients need treatment? Starting and stopping medication. Br Med J (Clin Res Ed) 1985 Jun 22;290(6485):1885–1888. doi: 10.1136/bmj.290.6485.1885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Covanis A., Gupta A. K., Jeavons P. M. Sodium valproate: monotherapy and polytherapy. Epilepsia. 1982 Dec;23(6):693–720. doi: 10.1111/j.1528-1157.1982.tb05085.x. [DOI] [PubMed] [Google Scholar]
  8. Duncan J. S., Sagar H. J. Seizure characteristics, pathology, and outcome after temporal lobectomy. Neurology. 1987 Mar;37(3):405–409. doi: 10.1212/wnl.37.3.405. [DOI] [PubMed] [Google Scholar]
  9. Duncan J. S., Shorvon S. D. Rates of antiepileptic drug reduction in active epilepsy--current practice. Epilepsy Res. 1987 Nov-Dec;1(6):357–364. doi: 10.1016/0920-1211(87)90060-x. [DOI] [PubMed] [Google Scholar]
  10. Duncan J. S., Shorvon S. D., Trimble M. R. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy. Epilepsia. 1990 May-Jun;31(3):324–333. doi: 10.1111/j.1528-1157.1990.tb05383.x. [DOI] [PubMed] [Google Scholar]
  11. Duncan J., Shorvon S. Prognosis of epilepsy. Br J Hosp Med. 1986 Apr;35(4):254–259. [PubMed] [Google Scholar]
  12. Falconer M. A., Taylor D. C. Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis. Etiology and significance. Arch Neurol. 1968 Oct;19(4):353–361. doi: 10.1001/archneur.1968.00480040019001. [DOI] [PubMed] [Google Scholar]
  13. Fischbacher E. Effect of reduction of anticonvulsants on wellbeing. Br Med J (Clin Res Ed) 1982 Aug 7;285(6339):423–424. doi: 10.1136/bmj.285.6339.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Franceschi M., Triulzi F., Ferini-Strambi L., Giusti M. C., Minicucci F., Fazio F., Smirne S., Del Maschio A. Focal cerebral lesions found by magnetic resonance imaging in cryptogenic nonrefractory temporal lobe epilepsy patients. Epilepsia. 1989 Sep-Oct;30(5):540–546. doi: 10.1111/j.1528-1157.1989.tb05469.x. [DOI] [PubMed] [Google Scholar]
  15. Gannaway D. J., Mawer G. E. Transfer from multiple to single antiepileptic drug therapy. Lancet. 1981 Jan 24;1(8213):217–217. doi: 10.1016/s0140-6736(81)90085-4. [DOI] [PubMed] [Google Scholar]
  16. Jeavons P. M., Clark J. E., Maheshwari M. C. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim"). Dev Med Child Neurol. 1977 Feb;19(1):9–25. doi: 10.1111/j.1469-8749.1977.tb08015.x. [DOI] [PubMed] [Google Scholar]
  17. Lesser R. P., Modic M. T., Weinstein M. A., Duchesneau P. M., Lüders H., Dinner D. S., Morris H. H., 3rd, Estes M., Chou S. M., Hahn J. F. Magnetic resonance imaging (1.5 tesla) in patients with intractable focal seizures. Arch Neurol. 1986 Apr;43(4):367–371. doi: 10.1001/archneur.1986.00520040049018. [DOI] [PubMed] [Google Scholar]
  18. Mattson R. H., Cramer J. A., Collins J. F., Smith D. B., Delgado-Escueta A. V., Browne T. R., Williamson P. D., Treiman D. M., McNamara J. O., McCutchen C. B. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 1985 Jul 18;313(3):145–151. doi: 10.1056/NEJM198507183130303. [DOI] [PubMed] [Google Scholar]
  19. Reynolds E. H., Shorvon S. D. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981 Feb;22(1):1–10. doi: 10.1111/j.1528-1157.1981.tb04327.x. [DOI] [PubMed] [Google Scholar]
  20. Roman E. J., Buchanan N., Lambert J. B., Barrah N. Rationalisation of therapy in severe epilepsy. Aust N Z J Med. 1983 Dec;13(6):601–604. doi: 10.1111/j.1445-5994.1983.tb02612.x. [DOI] [PubMed] [Google Scholar]
  21. Schmidt D. Reduction of two-drug therapy in intractable epilepsy. Epilepsia. 1983 Jun;24(3):368–376. doi: 10.1111/j.1528-1157.1983.tb04900.x. [DOI] [PubMed] [Google Scholar]
  22. Schmidt D., Richter K. Alternative single anticonvulsant drug therapy for refractory epilepsy. Ann Neurol. 1986 Jan;19(1):85–87. doi: 10.1002/ana.410190118. [DOI] [PubMed] [Google Scholar]
  23. Schmidt D. Two antiepileptic drugs for intractable epilepsy with complex-partial seizures. J Neurol Neurosurg Psychiatry. 1982 Dec;45(12):1119–1124. doi: 10.1136/jnnp.45.12.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shorvon S. D., Reynolds E. H. Reduction in polypharmacy for epilepsy. Br Med J. 1979 Oct 27;2(6197):1023–1025. doi: 10.1136/bmj.2.6197.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shorvon S. D., Reynolds E. H. Unnecessary polypharmacy for epilepsy. Br Med J. 1977 Jun 25;1(6077):1635–1637. doi: 10.1136/bmj.1.6077.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Theodore W. H., Porter R. J. Removal of sedative-hypnotic antiepileptic drugs from the regimens of patients with intractable epilepsy. Ann Neurol. 1983 Mar;13(3):320–324. doi: 10.1002/ana.410130316. [DOI] [PubMed] [Google Scholar]
  27. Thompson P. J., Trimble M. R. Anticonvulsant drugs and cognitive functions. Epilepsia. 1982 Oct;23(5):531–544. doi: 10.1111/j.1528-1157.1982.tb05439.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES